Key Facts/Product Summary
In the fight against human disease, we focus our resources on six therapy areas where we believe our skills and experience can make the most difference: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
You can view our Key Facts which which gives a brief description of AstraZeneca and details of our key products.
Click here for a full AstraZeneca product list, which includes product brand name, product generic name and therapy area.
R&D Pipeline
Information about our development pipeline is available in our Research section.
2008 Annual Report
The report is available as a dedicated website and includes link to download the full version as a PDF.
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 07:01 GMT
Detailed share priceIntroduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
